Cardiology

AstraZeneca’s COVID-19 Vaccine Enters Phase 2/3 Clinical Trial |


From the Website FierceBiotech comes some good news in the battle against COVID-19 Researchers at the University of Oxford have begun enrolling subjects in a phase 2/3 clinical trial of AstraZeneca-partnered COVID-19 vaccine AZD1222. The next stage of the program, which follows a 1,000-subject phase 1, is set to enroll 10,260 people in the U.K. … Continue reading AstraZeneca’s COVID-19 Vaccine Enters Phase 2/3 Clinical Trial |

The post AstraZeneca’s COVID-19 Vaccine Enters Phase 2/3 Clinical Trial | appeared first on The Skeptical Cardiologist.

Source link

Related posts

Atrial Fibrillation Development Predicted by Sleep Disruption

Newsemia

Admissions for Ischemic Stroke Among Younger Adults in Kentucky: A Comparison of Appalachian and Non-Appalachian Counties.

Newsemia

What causes heart disease part 46

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World